Technology | August 03, 2008

Low Energy Beam Delivers High-Dose

Intrabeam is a miniature radiation source that delivers high-dose, yet is a low energy X-ray used for breast cancer therapy, neurosurgery and other radiation therapies developed by Carl Zeiss Meditec.

The Intrabeam System can be used to treat early stage breast cancer. The radiation dose is administrated to the tumor bed in the operating room, following lumpectomy.

As a minimally invasive technique for stereotactic treatment delivery, following biopsy, the X-ray source probe directs the energy to the target, delivering the dose to the center of the tumor thereby minimizing radiation to healthy tissues.

During treatment delivery, an isotropic dose can be applied directly to the tumor bed, sparing healthy tissue and critical structures, which is said to maximize the amount of dose delivered to the target.

With the precision and control of brachytherapy and the flexibility of intraoperative treatment delivery, Intrabeam offers more options. The miniature X-ray source delivers up to 50kV of energy to the target tissue. Steep dose fall-off ensures that most of the dose stays in the target tissue. Spherical dose delivery that is safely and reliably delivered to tumors and tumor beds. Minimal shielding requirements mean safety for the patient and personnel. Typical treatment takes less than thirty minutes.

This high dose, low energy X-ray requires, according to the manufacturer, minimal shielding for personnel in the operating room, and there is no need to stand behind concrete walls or heavy beam-stopping equipment.

Related Content

RayStation Replacing Existing Treatment Planning System at Leeds Cancer Centre
News | Treatment Planning | September 24, 2018
RaySearch recently strengthened its position in the U.K. market with a major order for the treatment planning system...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...